344 related articles for article (PubMed ID: 33236138)
1. SphK1 promotes development of non‑small cell lung cancer through activation of STAT3.
Ma Y; Xing X; Kong R; Cheng C; Li S; Yang X; Li S; Zhao F; Sun L; Cao G
Int J Mol Med; 2021 Jan; 47(1):374-386. PubMed ID: 33236138
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.
Song L; Xiong H; Li J; Liao W; Wang L; Wu J; Li M
Clin Cancer Res; 2011 Apr; 17(7):1839-49. PubMed ID: 21325072
[TBL] [Abstract][Full Text] [Related]
3. SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis.
Qin Z; Tong H; Li T; Cao H; Zhu J; Yin S; He W
Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34549307
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
[TBL] [Abstract][Full Text] [Related]
5. ROS‑mediated hypomethylation of PRDX5 promotes STAT3 binding and activates the Nrf2 signaling pathway in NSCLC.
Cao X; Chen XM; Xiao WZ; Li B; Zhang B; Wu Q; Xue Q
Int J Mol Med; 2021 Feb; 47(2):573-582. PubMed ID: 33416106
[TBL] [Abstract][Full Text] [Related]
6. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S‑transferase ω 1 promotes the proliferation, migration and invasion, and inhibits the apoptosis of non‑small cell lung cancer cells, via the JAK/STAT3 signaling pathway.
Wang K; Zhang FL; Jia W
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236161
[TBL] [Abstract][Full Text] [Related]
8. Triptolide exerts an anti-tumor effect on non‑small cell lung cancer cells by inhibiting activation of the IL‑6/STAT3 axis.
Huang Y; Chen Z; Wang Y; Ba X; Huang Y; Shen P; Wang H; Tu S
Int J Mol Med; 2019 Jul; 44(1):291-300. PubMed ID: 31115521
[TBL] [Abstract][Full Text] [Related]
9. Raddeanin A induced apoptosis of non-small cell lung cancer cells by promoting ROS-mediated STAT3 inactivation.
Li L; Chen M; Li G; Cai R
Tissue Cell; 2021 Aug; 71():101577. PubMed ID: 34146943
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
Weerasinghe P; Garcia GE; Zhu Q; Yuan P; Feng L; Mao L; Jing N
Int J Oncol; 2007 Jul; 31(1):129-36. PubMed ID: 17549413
[TBL] [Abstract][Full Text] [Related]
11. PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapies.
Sen M; Kindsfather A; Danilova L; Zhang F; Colombo R; LaPorte MG; Kurland BF; Huryn DM; Wipf P; Herman JG
Epigenetics; 2020; 15(6-7):604-617. PubMed ID: 31595832
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
13. miR-125a regulates HAS1 and inhibits the proliferation, invasion and metastasis by targeting STAT3 in non-small cell lung cancer cells.
Huang H; Huang J; Yao J; Li N; Yang Z
J Cell Biochem; 2020 Jun; 121(5-6):3197-3207. PubMed ID: 31930562
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic relevance of STAT3 and cyclin D1 in non-small cell lung cancer.
Ai T; Wang Z; Zhang M; Zhang L; Wang N; Li W; Song L
Int J Biol Markers; 2012 Jul; 27(2):e132-8. PubMed ID: 22467101
[TBL] [Abstract][Full Text] [Related]
15. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
[TBL] [Abstract][Full Text] [Related]
16. MiR-124 Inhibits Growth and Enhances Radiation-Induced Apoptosis in Non-Small Cell Lung Cancer by Inhibiting STAT3.
Wang M; Meng B; Liu Y; Yu J; Chen Q; Liu Y
Cell Physiol Biochem; 2017; 44(5):2017-2028. PubMed ID: 29237164
[TBL] [Abstract][Full Text] [Related]
17. Fraxetin Suppresses Proliferation of Non-Small-Cell Lung Cancer Cells via Preventing Activation of Signal Transducer and Activator of Transcription 3.
Zhang Y; Wang L; Deng Y; Zhao P; Deng W; Zhang J; Luo J; Li R
Tohoku J Exp Med; 2019 May; 248(1):3-12. PubMed ID: 31080186
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation.
Wang X; Chen Z
Int J Mol Med; 2015 Mar; 35(3):839-46. PubMed ID: 25604748
[TBL] [Abstract][Full Text] [Related]
19. Expression of activated and latent signal transducer and activator of transcription 3 in 303 non-small cell lung carcinomas and 44 malignant mesotheliomas: possible role for chemotherapeutic intervention.
Achcar Rde O; Cagle PT; Jagirdar J
Arch Pathol Lab Med; 2007 Sep; 131(9):1350-60. PubMed ID: 17824789
[TBL] [Abstract][Full Text] [Related]
20. Suppression of EGFR/STAT3 activity by lupeol contributes to the induction of the apoptosis of human non‑small cell lung cancer cells.
Min TR; Park HJ; Ha KT; Chi GY; Choi YH; Park SH
Int J Oncol; 2019 Jul; 55(1):320-330. PubMed ID: 31115519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
